article thumbnail

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Xconomy

Plans for new incubators were announced in two different cities. —Two more clinical setbacks decimated the shares of Massachusetts biotechs: Ocular Therapeutix’s (NASDAQ: OCUL ) OTX-DP failed a trial for allergic conjunctivitis , while Catabasis Pharmaceuticals’ (NASDAQ: CATB ) CAT-2054 flunked a study in patients with high cholesterol.

article thumbnail

Makers Making The Sci-Fi Tricorder A Reality With VOXearch

socalTECH

Our first project was 3D imaging of the heart, so that doctors could study a pacemaker and defibrillator recall from the Alfred E. This is really also funded because of Mike and my other project, the 101 incubator. I''ve worked in the movie business, movie, audio, imaging. Mann implantable device area.

Startup 262